A quantitative radioimmunoassay for DNA-binding antibodies

Area of Science:

• Immunology
• Biochemistry
• Clinical Diagnostics

Background:

• Antibodies to DNA are significant biomarkers in Systemic Lupus Erythematosus (SLE).
• Accurate quantitative measurement and class determination of these antibodies are vital for monitoring SLE patient status.
• Existing methods may lack the specificity or quantitative precision required for comprehensive assessment.

Purpose of the Study:

• To develop and describe a Radioimmunoassay (RIA) for quantifying serum immunoglobulins that bind to double-stranded (dsDNA) and single-stranded (ssDNA).
• To enable the determination of the fraction of total serum IgM and IgG that is specific for DNA.
• To provide a tool for monitoring the status of patients with SLE through quantitative antibody measurements.

Main Methods:

• DNA immobilized on Sephadex G-50 via UV irradiation served as a solid-phase immunoabsorbent for DNA-binding proteins in serum.
• 125I-labeled and 131I-labeled anti-human IgG and IgM were used to detect bound human immunoglobulins.
• Quantities were determined using a standard curve from SLE patient plasma; a separate RIA measured total IgG and IgM levels.

Main Results:

• The RIA successfully quantified DNA-binding IgG and IgM in serum.
• In normal human sera, specific antibody fractions were low: 0.04% total IgM and 0.001% total IgG bound dsDNA; 0.22% total IgM and 0.05% total IgG bound ssDNA.
• The assay allows for the determination of the proportion of DNA-specific antibodies within the total immunoglobulin pool.

Conclusions:

• The developed RIA provides a quantitative method for measuring DNA-binding immunoglobulins (IgG and IgM) in serum.
• This assay facilitates the determination of the fraction of total immunoglobulins specific to DNA.
• The quantitative measurement and class determination of anti-DNA antibodies are significant for monitoring SLE patient status.